IV Post

Washington, DC - The U.S. Food and Drug Administration today licensed for marketing the first product in the United States intended to protect people with hereditary angioedema (HAE), a rare and potentially life-threatening genetic disease. HAE affects about 6,000 to 10,000 individuals in the United States.

Washington, DC - The United States Food and Drug Administration in collaboration with the Centers for Disease Control and Prevention and the U.S. Department of Agriculture launched its food defense awareness training kit for first line food industry employees. The training targets these individuals because they can play an important role in helping to keep our nation's food supply safe, from the farm to the table.

Washington, DC - National Institutes of Health (NIH) scientists have identified a protein that plays matchmaker between two key types of white blood cells, T and B cells, enabling them to interact in a way that is crucial to establishing long-lasting immunity after an infection.

Washington, DC - The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), will award five-year contracts estimated to be up to $68.7 million to establish programs in Systems Biology for Infectious Disease Research at four research institutions. Scientists at each facility will apply novel techniques to study diseases that include severe acute respiratory syndrome (SARS), tuberculosis and influenza.

Dallas, Texas - UT Southwestern Medical Center has partnered with Susan G. Komen for the Cure and will be collecting blood samples at the Dallas Komen Race on Oct. 18 at NorthPark Center for use in breast cancer research.